These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35187608)
1. Canavan's spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature. Rossler L; Lemburg S; Weitkämper A; Thiels C; Hoffjan S; Nguyen HP; Lücke T; Heyer CM J Ultrasound; 2023 Dec; 26(4):757-764. PubMed ID: 35187608 [TBL] [Abstract][Full Text] [Related]
3. Molecular basis of Canavan's disease: from human to mouse. Surendran S; Matalon KM; Tyring SK; Matalon R J Child Neurol; 2003 Sep; 18(9):604-10. PubMed ID: 14572138 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound findings in follow-up investigations in a case of aspartoacylase deficiency (canavan disease). Breitbach-Faller N; Schrader K; Rating D; Wunsch R Neuropediatrics; 2003 Apr; 34(2):96-9. PubMed ID: 12776232 [TBL] [Abstract][Full Text] [Related]
5. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. Baslow MH J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786 [TBL] [Abstract][Full Text] [Related]
6. Novel mutation in an Egyptian patient with infantile Canavan disease. Zaki OK; El Abd HS; Mohamed SA; Zayed H Metab Brain Dis; 2016 Jun; 31(3):573-7. PubMed ID: 26613958 [TBL] [Abstract][Full Text] [Related]
7. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease. Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961 [TBL] [Abstract][Full Text] [Related]
8. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease. Aydinli N; Calişkan M; Calay M; Ozmen M Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864 [TBL] [Abstract][Full Text] [Related]
9. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease. Eke GH; Iscan A; Cece H; Calik M Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636 [TBL] [Abstract][Full Text] [Related]
14. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene. Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572 [TBL] [Abstract][Full Text] [Related]
15. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion. Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223 [TBL] [Abstract][Full Text] [Related]
16. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings. Matalon RM; Michals-Matalon K Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428 [TBL] [Abstract][Full Text] [Related]
17. A case of juvenile Canavan disease with distinct pons involvement. Çakar NE; Aksu Uzunhan T Brain Dev; 2020 Feb; 42(2):222-225. PubMed ID: 31839386 [TBL] [Abstract][Full Text] [Related]
18. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature. Merrill ST; Nelson GR; Longo N; Bonkowsky JL Orphanet J Rare Dis; 2016 Dec; 11(1):169. PubMed ID: 27927234 [TBL] [Abstract][Full Text] [Related]
20. A case of Canavan disease with microcephaly. Gowda VK; Bhat MD; Srinivasan VM; Prasad C; Benakappa A; Faruq M Brain Dev; 2016 Sep; 38(8):759-62. PubMed ID: 26992473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]